University of Chicago Comprehensive Cancer Center at Silver Cross

New Lenox, Illinois 60451

1 studies enrolling now · 1 studies all time

What they study most

HER2-positive Metastatic Breast Cancer

Studies at this site

• QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer — Recruiting now